KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Net Margin: 2009-2014

Historic Net Margin for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -372.40%.

  • Biocryst Pharmaceuticals' Net Margin rose 26584.00% to -129.87% in Q3 2015 from the same period last year, while for Sep 2015 it was -93.64%, marking a year-over-year increase of 12956.00%. This contributed to the annual value of -372.40% for FY2014, which is 16813.00% down from last year.
  • Biocryst Pharmaceuticals' Net Margin amounted to -372.40% in FY2014, which was down 82.31% from -204.27% recorded in FY2013.
  • Biocryst Pharmaceuticals' Net Margin's 5-year high stood at -54.27% during FY2010, with a 5-year trough of -372.40% in FY2014.
  • Its 3-year average for Net Margin is -240.82%, with a median of -204.27% in 2013.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Net Margin crashed by 21,528bps in 2011, and later soared by 12,376bps in 2012.
  • Over the past 5 years, Biocryst Pharmaceuticals' Net Margin (Yearly) stood at -54.27% in 2010, then tumbled by 21,528bps to -269.55% in 2011, then surged by 12,376bps to -145.79% in 2012, then plummeted by 5,848bps to -204.27% in 2013, then crashed by 16,813bps to -372.40% in 2014.